Novel therapy for COVID-19 does intravenous ozonated-saline affect blood and tissue oxygenation?
<p>Introduction: Adjunctive ozone therapy for COVID-19 is being used successfully in China, Spain, Italy, and South America. One proposed mechanism is by improving blood / tissue oxygenation thus averting multiorgan system failure due to hypoxia. The purpose of this study was to determine if o...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Journal of Gynecological Research and Obstetrics - Peertechz Publications,
2020-06-10.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | <p>Introduction: Adjunctive ozone therapy for COVID-19 is being used successfully in China, Spain, Italy, and South America. One proposed mechanism is by improving blood / tissue oxygenation thus averting multiorgan system failure due to hypoxia. The purpose of this study was to determine if ozonated-saline administered intravenously affects the oxygenation and duration of time spent in a hypoxia chamber.</p><br><p>Materials and methods: This was a prospective pilot study that used one volunteer who underwent seven experiments. Each included two runs in a hypoxia chamber that resulted in symptomatic oxygen desaturation. One subject was used as his own control in the hypoxia chamber before and after infusion of intravenous ozonated-saline in four paired experiments.Another 3 experiments were performed identically except ozone was not administered. The primary outcome was to test the null hypothesis that ozonated-saline infusion does not affect oxygenation.</p><br><p>Results: In four experiments, ozone was associated with a significant increase in time the subject could remain in the hypoxia chamber (P< 0.05). In three control experiments without ozone, there was a significant decrease in time in the hypoxia chamber in the second run compared to the first (P <0.001). Compared to the first run there was a 32.4% increase in the proportion of time in the second run (after ozone) compared to the first run (P <0.0001). In contrast, in the three control experiments without ozone, there was significant decrease in proportion of time the subject could remain in the hypoxia chamber with an average decrease of -43.1% (P < 0.0001). Ozone therapy was associated with a significant delay in lowest oxygen desaturation (P <0.05). In contrast, in the three experimental runs without ozone there was a significant reduction in time to reach the nadir of the desaturation curve in the second run compared to that of the first (P < 0.05).</p><br><p>Conclusions: Infusion of intravenous ozonated-saline significantly increases the duration of time that a subject can remain in hypoxia and delays the nadir of the oxygen de-saturation curve.</p> |
|---|---|
| DOI: | 10.17352/jgro.000085 |